Hillsdale Investment Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,200
Closed -$11K 689
2019
Q4
$11K Hold
1,200
﹤0.01% 488
2019
Q3
$11K Hold
1,200
﹤0.01% 498
2019
Q2
$12K Hold
1,200
﹤0.01% 489
2019
Q1
$17K Buy
1,200
+100
+9% +$1.72K ﹤0.01% 475
2018
Q4
$17K Buy
1,100
+200
+22% +$3.45K ﹤0.01% 450
2018
Q3
$17K Buy
900
+100
+13% +$1.99K ﹤0.01% 336
2018
Q2
$15K Buy
+800
New +$16.2K ﹤0.01% 359
2015
Q1
Sell
-14,530
Closed -$220K 580
2014
Q4
$220K Hold
14,530
0.06% 317
2014
Q3
$206K Hold
14,530
0.07% 300
2014
Q2
$206K Hold
14,530
0.05% 320
2014
Q1
$249K Buy
+14,530
New +$241K 0.07% 260

Other funds holding PMD

Hillsdale Investment Management's PMD Position: Q1 2020 in Review

Hillsdale Investment Management sold out of Psychemedics Corporation (PMD) in Q1 2020, closing a stake of 1,200 shares — an estimated $11K sold.

Hillsdale Investment Management first reported a position in PMD in Q1 2014 and held it in 11 quarters. The position peaked at $249K in Q1 2014. 37 funds tracked by Wall St. Rank hold PMD as of Q1 2020.

  • Hillsdale Investment Management reported no remaining Psychemedics Corporation position as of Q1 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,200 Psychemedics Corporation shares in Q1 2020, an estimated $11K.
  • Hillsdale Investment Management first reported a position in Psychemedics Corporation in Q1 2014 and held it in 11 quarters.
  • Hillsdale Investment Management's Psychemedics Corporation position peaked at $249K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2020.

Based on Hillsdale Investment Management's 13F filing for Q1 2020, filed 12 May 2020.